Thank I'm Andrew Huberman, and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine
Such symptoms, however, including anosmia (although not to the extent seen in the first wave of COVID-19), may be expected in anyone recovering from a severe viral illness because of cytokine release, critical illness encephalopathy or medication 3
No injectable or systemic formulations are FDA-approved for any indication as of February 14, 2026 [11]
Frequently Asked Questions Glossary References Sikiric P, et al
When food stays in the stomach for longer periods, it may also cause discomfort and sometimes nausea
(2003) demonstrated that Epithalon increased telomerase activity in human somatic cells by 2.4-fold A 15-year follow-up study of elderly patients showed that those receiving peptide bioregulators (including Epithalon) had a 28% reduction in mortality compared to controls Animal studies have shown increased lifespan of up to 13.3% in organisms treated with Epithalon, as reported in research published through the National Institute on Aging Studies on retinal pigment epithelium cells showed Epithalons ability to reactivate telomerase in senescent cells While more large-scale human clinical trials are needed, the existing body of research is substantial and encouraging
